Oncology Institute (TOIIW) Leases (2022 - 2026)

Oncology Institute (TOIIW) has 5 years of Leases data on file, last reported at $22.5 million in Q1 2026.

• For the quarter ending Q1 2026, Leases fell 6.98% year-over-year to $22.5 million; the trailing twelve-month figure through Mar 2026 stood at $22.5 million (down 6.98% YoY), and the FY2025 full-year result was $22.4 million, down 13.22% from the prior year.
• Leases for Q1 2026 stood at $22.5 million, up from $22.4 million in the prior quarter.
• Across five years, Leases topped out at $29.2 million in Q4 2023 and bottomed at $17.2 million in Q1 2022.
• The 5-year median for Leases is $24.7 million (2023), against an average of $24.6 million.
• The widest annual swing landed in 2023, when Leases soared 68.3%; it then declined 14.1% in 2025.
• A 5-year view of Leases shows it stood at $24.5 million in 2022, then rose by 19.09% to $29.2 million in 2023, then slipped by 11.61% to $25.8 million in 2024, then fell by 13.22% to $22.4 million in 2025, then grew by 0.65% to $22.5 million in 2026.
• The last three Leases figures came in at $22.5 million (Q1 2026), $22.4 million (Q4 2025), and $23.3 million (Q3 2025), per Business Quant data.

Peer Comparison